Receptor tyrosine kinases as targets for anticancer drugs
Year: 2002
Type: review
Source: Trends in Molecular Medicine
Authors: Esther Zwick, Johannes Bange, Axel Ullrich
Institutions: Max Planck Institute of Biochemistry, Max Planck Society
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1984375602
